These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 15086420)
1. The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells. Tarte K; Jourdan M; Veyrune JL; Berberich I; Fiol G; Redal N; Shaughnessy J; Klein B Br J Haematol; 2004 May; 125(3):373-82. PubMed ID: 15086420 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line. Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562 [TBL] [Abstract][Full Text] [Related]
3. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Jourdan M; De Vos J; Mechti N; Klein B Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens. Park J; Kim M; Na G; Jeon I; Kwon YK; Kim JH; Youn H; Koo Y Mol Cell Endocrinol; 2007 Nov; 278(1-2):7-17. PubMed ID: 17870233 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. Brien G; Trescol-Biemont MC; Bonnefoy-Bérard N Oncogene; 2007 Aug; 26(39):5828-32. PubMed ID: 17353899 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of bfl-1/A1 by siRNA inhibits mycobacterial growth in THP-1 cells by enhancing phagosomal acidification. Dhiman R; Kathania M; Raje M; Majumdar S Biochim Biophys Acta; 2008 Apr; 1780(4):733-42. PubMed ID: 18206119 [TBL] [Abstract][Full Text] [Related]
7. The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling. Vier J; Groth M; Sochalska M; Kirschnek S Cell Death Dis; 2016 Feb; 7(2):e2103. PubMed ID: 26890142 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Olsson A; Norberg M; Okvist A; Derkow K; Choudhury A; Tobin G; Celsing F; Osterborg A; Rosenquist R; Jondal M; Osorio LM Br J Cancer; 2007 Sep; 97(6):769-77. PubMed ID: 17726463 [TBL] [Abstract][Full Text] [Related]
9. Bfl-1/A1 acts as a negative regulator of autophagy in mycobacteria infected macrophages. Kathania M; Raje CI; Raje M; Dutta RK; Majumdar S Int J Biochem Cell Biol; 2011 Apr; 43(4):573-85. PubMed ID: 21167304 [TBL] [Abstract][Full Text] [Related]
10. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680 [TBL] [Abstract][Full Text] [Related]
11. Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Ko JK; Lee MJ; Cho SH; Cho JA; Lee BY; Koh JS; Lee SS; Shim YH; Kim CW Oncogene; 2003 Apr; 22(16):2457-65. PubMed ID: 12717423 [TBL] [Abstract][Full Text] [Related]
12. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464 [TBL] [Abstract][Full Text] [Related]
13. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Jourdan M; Veyrune JL; De Vos J; Redal N; Couderc G; Klein B Oncogene; 2003 May; 22(19):2950-9. PubMed ID: 12771946 [TBL] [Abstract][Full Text] [Related]
14. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232 [TBL] [Abstract][Full Text] [Related]
15. Bfl-1 is a crucial pro-survival nuclear factor-κB target gene in Hodgkin/Reed-Sternberg cells. Loughran ST; Campion EM; D'Souza BN; Smith SM; Vrzalikova K; Wen K; Murray PG; Walls D Int J Cancer; 2011 Dec; 129(12):2787-96. PubMed ID: 21491422 [TBL] [Abstract][Full Text] [Related]
16. Regulation of A1/Bfl-1 expression in peripheral splenic B cells. Trescol-Biémont MC; Verschelde C; Cottalorda A; Bonnefoy-Bérard N Biochimie; 2004; 86(4-5):287-94. PubMed ID: 15194232 [TBL] [Abstract][Full Text] [Related]
17. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402 [TBL] [Abstract][Full Text] [Related]
18. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Zong WX; Edelstein LC; Chen C; Bash J; Gélinas C Genes Dev; 1999 Feb; 13(4):382-7. PubMed ID: 10049353 [TBL] [Abstract][Full Text] [Related]
20. Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family. Knödel M; Kuss AW; Lindemann D; Berberich I; Schimpl A Eur J Immunol; 1999 Sep; 29(9):2988-98. PubMed ID: 10508273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]